Mismatch repair deficiency in metastatic prostate cancer: Response to PD-1 blockade and standard therapies.
Graham LS, Montgomery B, Cheng HH, Yu EY, Nelson PS, Pritchard C, Erickson S, Alva A, Schweizer MT. Mismatch repair deficiency in metastatic prostate cancer: Response to PD-1 blockade and standard therapies. PLoS One. 2020; 15(5):e0233260.